Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2006, p. 2869-2871, Vol. 50, No. 8
0066-4804/06/$08.00+0 doi:10.1128/AAC.00270-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Pharmaceutical Research Center, Meiji Seika Kaisha Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan
Received 3 March 2006/ Returned for modification 20 March 2006/ Accepted 4 May 2006
AG205 was identified from high-throughput screening as a potent inhibitor of FabK, the enoyl-ACP reductase in Streptococcus pneumoniae. Specific inhibition of lipid biosynthesis in a macromolecular biosynthesis assay and identification of an Ala141Ser substitution in FabK from spontaneous AG205-resistant mutants indicated that AG205 exerts antibacterial activity against S. pneumoniae through the specific inhibition of FabK.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»